【摘要】 目的:探讨康艾与艾迪注射液联合化疗治疗非小细胞肺癌的疗效。方法:将90例非小细胞肺癌患者分为A、B、C3组各30例,A组采用康艾注射液联合GP化疗方案治疗,B组采用艾迪注射液联合GP化疗方案治疗,C组仅采用GP化疗方案治疗,观察3组临床疗效、治疗前后生活质量评分和毒副反应。结果:A、B组在临床疗效、生活质量评分、毒副反应发生率方面明显优于C组(P<0.05),;A、B组之间比较,差异无统计学意义(P>0.05)。结论:采用康艾与艾迪注射液联合GP化疗方案治疗非小细胞肺癌,能够有效缓解患者的临床症状,减少毒副反应,提高生活质量。更多还原

【Abstract】 Objective: To study the clinical effect of Kang’ai and Aidi injection combined with chemotherapy on non-small cell lung cancer. Method: The 90 cases were divided into A, B, C three groups, 30 cases in each. Group A were treated with Kang’ai injection combined with GP chemotherapy, Group B was given Aidi injection combined with GP chemotherapy, while Group C only received GP chemotherapy. Then the clinical effects, ratings of life quality before and after treatment, toxic and side reactions of three groups were observed. Results: Group A and B was significantly better than group C in clinical efficacy,quality of life score and the incidence of toxic and side reactions(P<0.05), but there is no significant difference between group A and B(P>0.05). Conclusion: Kang’ai and Aidi injection combined with GP chemotherapy can effectively relieve the patients’ clinical symptoms, reduce the toxic and side reactions, and improve the patients’ quality of life.更多还原